Literature DB >> 30376348

Insulin signaling in LepR cells modulates fat and glucose homeostasis independent of leptin.

Beatriz C Borges1,2, Xingfa Han1,3, Susan J Allen1, David Garcia-Galiano1, Carol F Elias1,4.   

Abstract

Hypothalamic neurons detect changes in circulating hormones such as leptin and insulin and put forward outputs to sustain energy and glucose homeostasis. Because leptin and insulin receptors colocalize in ~40-60% of neurons in the hypothalamus, we characterized the metabolic phenotype of mice with selective deletion of the insulin receptor (InsR) in LepR cells. LRΔInsR mice presented no difference in body weight and insulin levels but increased fat mass. In the light phase, LRΔInsR mice exhibited increased food intake, locomotor activity, carbon dioxide production, and respiratory exchange rate. These mice showed reduced fat oxidation and reduced expression of cluster of differentiation 36 and AMP-activated protein kinase-α1 in the liver, increased glucose oxidation in the light phase, and overall reduced basal glucose levels. To verify the impact of InsR deletion in LepR cells in obesity, we generated ob/ ob InsRfl, ob/ ob LRcre, and ob/ ob LRΔInsR mice. The ob/ ob LRΔInsR mice had higher body weight, fat mass, and expression of genes related to fat metabolism in the liver. No difference in food intake despite increased neuropeptide Y and agouti-related peptide expression, and no difference in energy expenditure, fat, or glucose oxidation was found in ob/ ob LRΔInsR compared with LRcre or LRΔInsR controls. Remarkably, basal glucose levels were reduced, and the expression of genes associated with glucose metabolism in the liver was higher. Insulin signaling in LepR cells is required for the proper fat and glucose oxidation. These effects are independent of leptin given that the leptin-deficient ob/ ob LRΔInsR mice also presented reduced glycemia and higher adiposity. The mechanisms underlying these responses remain to be unveiled.

Entities:  

Keywords:  adiposity; glycemia; hypothalamus; insulin receptor; leptin deficiency

Mesh:

Substances:

Year:  2018        PMID: 30376348      PMCID: PMC6417687          DOI: 10.1152/ajpendo.00287.2018

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  55 in total

1.  Arcuate nucleus-specific leptin receptor gene therapy attenuates the obesity phenotype of Koletsky (fa(k)/fa(k)) rats.

Authors:  Gregory J Morton; Kevin D Niswender; Christopher J Rhodes; Martin G Myers; James E Blevins; Denis G Baskin; Michael W Schwartz
Journal:  Endocrinology       Date:  2003-05       Impact factor: 4.736

2.  Insulin action in the brain contributes to glucose lowering during insulin treatment of diabetes.

Authors:  Richard W Gelling; Gregory J Morton; Christopher D Morrison; Kevin D Niswender; Martin G Myers; Christopher J Rhodes; Michael W Schwartz
Journal:  Cell Metab       Date:  2006-01       Impact factor: 27.287

3.  Diabetes, obesity, and the brain.

Authors:  Michael W Schwartz; Daniel Porte
Journal:  Science       Date:  2005-01-21       Impact factor: 47.728

4.  Cellular energy sensors: AMPK and beyond.

Authors:  Miguel López; Carlos Diéguez
Journal:  Mol Cell Endocrinol       Date:  2014-11-18       Impact factor: 4.102

5.  A guide to analysis of mouse energy metabolism.

Authors:  Matthias H Tschöp; John R Speakman; Jonathan R S Arch; Johan Auwerx; Jens C Brüning; Lawrence Chan; Robert H Eckel; Robert V Farese; Jose E Galgani; Catherine Hambly; Mark A Herman; Tamas L Horvath; Barbara B Kahn; Sara C Kozma; Eleftheria Maratos-Flier; Timo D Müller; Heike Münzberg; Paul T Pfluger; Leona Plum; Marc L Reitman; Kamal Rahmouni; Gerald I Shulman; George Thomas; C Ronald Kahn; Eric Ravussin
Journal:  Nat Methods       Date:  2011-12-28       Impact factor: 28.547

6.  Fasting regulates hypothalamic neuropeptide Y, agouti-related peptide, and proopiomelanocortin in diabetic mice independent of changes in leptin or insulin.

Authors:  T M Mizuno; H Makimura; J Silverstein; J L Roberts; T Lopingco; C V Mobbs
Journal:  Endocrinology       Date:  1999-10       Impact factor: 4.736

7.  Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis.

Authors:  Nina Balthasar; Roberto Coppari; Julie McMinn; Shun M Liu; Charlotte E Lee; Vinsee Tang; Christopher D Kenny; Robert A McGovern; Streamson C Chua; Joel K Elmquist; Bradford B Lowell
Journal:  Neuron       Date:  2004-06-24       Impact factor: 17.173

8.  Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production.

Authors:  A Christine Könner; Ruth Janoschek; Leona Plum; Sabine D Jordan; Eva Rother; Xiaosong Ma; Chun Xu; Pablo Enriori; Brigitte Hampel; Gregory S Barsh; C Ronald Kahn; Michael A Cowley; Frances M Ashcroft; Jens C Brüning
Journal:  Cell Metab       Date:  2007-06       Impact factor: 27.287

9.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

10.  Identification and expression cloning of a leptin receptor, OB-R.

Authors:  L A Tartaglia; M Dembski; X Weng; N Deng; J Culpepper; R Devos; G J Richards; L A Campfield; F T Clark; J Deeds; C Muir; S Sanker; A Moriarty; K J Moore; J S Smutko; G G Mays; E A Wool; C A Monroe; R I Tepper
Journal:  Cell       Date:  1995-12-29       Impact factor: 41.582

View more
  1 in total

Review 1.  PI3K signalling in leptin receptor cells: Role in growth and reproduction.

Authors:  David Garcia-Galiano; Beatriz C Borges; Susan J Allen; Carol F Elias
Journal:  J Neuroendocrinol       Date:  2019-01-28       Impact factor: 3.627

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.